1. Home
  2. STSS vs ICCM Comparison

STSS vs ICCM Comparison

Compare STSS & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sharps Technology Inc.

STSS

Sharps Technology Inc.

HOLD

Current Price

$1.84

Market Cap

43.8M

Sector

Health Care

ML Signal

HOLD

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$2.39

Market Cap

41.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
STSS
ICCM
Founded
2017
2006
Country
United States
Israel
Employees
55
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
41.4M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
STSS
ICCM
Price
$1.84
$2.39
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
169.6K
1.0M
Earning Date
04-06-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$139.51
Revenue Next Year
N/A
$75.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.42
$0.13
52 Week High
$18.23
$5.69

Technical Indicators

Market Signals
Indicator
STSS
ICCM
Relative Strength Index (RSI) 48.87 58.94
Support Level $1.66 $0.52
Resistance Level $2.00 $5.69
Average True Range (ATR) 0.11 0.43
MACD -0.02 0.16
Stochastic Oscillator 25.00 41.24

Price Performance

Historical Comparison
STSS
ICCM

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: